Home
Home
/
Products
Products
/
Bioactive Compounds
Bioactive Compounds
/
JAK/STAT Signaling
JAK/STAT Signaling
/
FLT3
FLT3
FLT3
Products (19)
Rebastinib
CAS No.:
1020172-07-9
trans-4-(2-(Butylamino)-5-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol
CAS No.:
1429881-91-3
Crenolanib
CAS No.:
670220-88-9
Fostamatinib Disodium Anhydrous
CAS No.:
1025687-58-4
Ripretinib
CAS No.:
1442472-39-0
Pexidartinib
CAS No.:
1029044-16-3
Quizartinib
CAS No.:
950769-58-1
Dovitinib
CAS No.:
405169-16-6
Famitinib
CAS No.:
1044040-56-3
Quizartinib Dihydrochloride
CAS No.:
1132827-21-4
Sitravatinib
CAS No.:
1123837-84-2
Luxeptinib
CAS No.:
1616428-23-9
Foretinib
CAS No.:
849217-64-7
4Sc-203
CAS No.:
895533-09-2
7-(4-Fluoro-2-methoxyphenyl)-6-methyl-N-(1-(piperidin-4-yl)-1H-pyrazol-4-yl) thieno (3,2-d)pyrimidin-2-amine
CAS No.:
2070931-57-4
Idrx-42
CAS No.:
2590556-80-0
Mivavotinib
CAS No.:
1312691-33-0
Tuspetinib
CAS No.:
2294874-49-8
Linifanib
CAS No.:
796967-16-3
Products
CDMO Compounds
API & Candidates
Services
CDMO & Manufacturing
Custom Synthesis
Process Development
Lab To Pilot
Commercialization
Generic APIs
CRO
Preclinical
Pharmacology & Efficacy
DMPK & Bioanalysis
Toxicology & Safety
Disease Models
Technologies
High-Potent
Chiral Synthesis
Cloud Synthesis
Fermentation
Flow Chemistry
Biocatalysis
Support
Regulatory Support
Supply Chain Solutions
About
Perspectives
Contact